Drawing for ZIPHIUS

USPTO serial 79366407

ZIPHIUS

Reviewed by CopyMark Law Group

Reg. 7490625Status 700Registered
Filing date
Status date
Registration date
Sep 3, 2024
Examiner
TURNER, JASON FITZGERALD
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ZIPHIUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrea S. Fuelleman

Andrea S. Fuelleman Neal, Gerber & Eisenberg LLPTwo North LaSalle Street, Suite 1700Chicago, IL 60602United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders, infectious diseases, parasitic diseases, and oncology in the field of cystic Fibrosis, chlamydia trachomatis, eppstein barr, herpes zoster, herpes simplex, coronaviruses, malaria, leishmaniasis, and trypanosomiasis; chikungunya, dengue, lymphatic filariasis, rift valley fever, yellow fever, zika, malaria, Japanese encephalitis, West Nile fever, schistosomiasis (bilharziasis), Onchocerciasis (river blindness), plagues, tungiasis, typhus, louse-borne relapsing fever, Leishmaniasis, Sandfly fever (Phlebotomus fever), Crimean Congo haemorrhagic fever, Lyme disease, Relapsing fever (borreliosis), rickettsial diseases, Tick-borne encephalitis, tularaemia, chagas disease (American trypanosomiasis), sleeping sickness (African trypanosomiasis), all of the foregoing based on self-amplifying RNA and Lipid based delivery vehicles; vaccinesACTIVE—
009Downloadable mobile applications and downloadable computer software to enable healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; Downloadable e-commerce software to enable users to perform electronic business transactions via a global computer network; Downloadable computer software to enable professionals to optimize workflow, capture and organize information, place orders and track expensesACTIVE—
010Surgical apparatus and instruments for medical use; blood pressure and diabetic diagnostic medical devicesACTIVE—
035Provision of information and advisory services relating to electronic commerce; provision of customer information on pharmaceutical and medical products through an on-line computer network for advertising purposesACTIVE—
042Scientific research for medical purposesACTIVE—
044Medical services and healthcare services namely, offered through a network of healthcare providers on a contract basis; provision of medical information; provision of medical information to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments via the Internet; gene therapy and stem cell therapy services; medical and psychological counselling services; medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 13, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 8, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 18, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 18, 2025FIMPFINAL DISPOSITION PROCESSED—
Dec 3, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 28, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 14, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 3, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 3, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 28, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 28, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 1, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jun 18, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 18, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 11, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 11, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 29, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 16, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 15, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 14, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 14, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 2, 2024RFNTREFUSAL PROCESSED BY IB—
Dec 11, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 11, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 8, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 7, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2023RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Dec 3, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 2, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2023DOCKASSIGNED TO EXAMINER—
Apr 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 30, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance